Trials / Sponsors / City of Hope Medical Center
City of Hope Medical Center
Academic / Other · 636 registered clinical trials — 161 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell T Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified, Recurrent Primary Mediastinal Large B-Cell Lymphoma | Phase 2 | 2026-12-30 |
| Not Yet Recruiting | RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy Advanced Clear Cell Renal Cell Carcinoma, Advanced Renal Cell Carcinoma, Advanced Sarcomatoid Renal Cell Carcinoma | Phase 2 | 2026-08-11 |
| Not Yet Recruiting | Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Advanced Microsatellite Stable Colorectal Carcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma, Stage III Colorectal Cancer AJCC v8 | Phase 1 | 2026-07-21 |
| Withdrawn | Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gyn Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Endometrial Carcinoma | N/A | 2026-07-16 |
| Not Yet Recruiting | Geriatric Assessment and Management for Older Adults Undergoing Chemotherapy and Radiation Therapy for Head an Localized Head and Neck Carcinoma | N/A | 2026-07-09 |
| Not Yet Recruiting | Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix Metastatic Appendix Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Peritoneum | Phase 3 | 2026-07-01 |
| Not Yet Recruiting | Pembrolizumab in Combination With Chemotherapy for the Treatment of Frail Hodgkin Lymphoma Patients Ineligible Classic Hodgkin Lymphoma | Phase 2 | 2026-07-01 |
| Not Yet Recruiting | Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer Localized Clear Cell Renal Cell Carcinoma, Resectable Clear Cell Renal Cell Carcinoma, Stage II Renal Cell Cancer AJCC v8 | Phase 2 | 2026-06-08 |
| Not Yet Recruiting | Duvelisib Maintenance for the Treatment of Peripheral T-Cell Lymphomas Follicular Helper T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Not Otherwise Specified | Phase 2 | 2026-06-07 |
| Recruiting | Pacritinib in Combination With a BTK Inhibitor for the Treatment of Patients With Relapsed or Refractory Mantl Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma | Phase 1 | 2026-06-01 |
| Not Yet Recruiting | Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogen Graft Versus Host Disease, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | — | 2026-06-01 |
| Recruiting | Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed Recurrent B Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia | Phase 1 | 2026-06-01 |
| Not Yet Recruiting | Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of G Acute Myeloid Leukemia, Graft Versus Host Disease, Myelodysplastic Syndrome | Phase 1 | 2026-05-25 |
| Suspended | Circulating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast Cancer Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | N/A | 2026-05-12 |
| Recruiting | A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Vir Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 1 | 2026-05-08 |
| Not Yet Recruiting | Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Su Clear Cell Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma, Stage II Renal Cell Cancer AJCC v8 | Phase 2 | 2026-05-04 |
| Not Yet Recruiting | Asciminib as Maintenance Treatment After Cellular Therapies for Adults With Philadelphia Chromosome Positive A B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Phase 1 | 2026-05-01 |
| Not Yet Recruiting | Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cel Follicular Helper T-Cell Lymphoma, Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type, Follicular Helper T-Cell Lymphoma, Follicular-Type | Phase 1 | 2026-04-27 |
| Recruiting | Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients Wit Thyroid Gland Nodule | — | 2026-04-25 |
| Recruiting | Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-lin Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 | Phase 2 | 2026-04-08 |
| Not Yet Recruiting | Exercise and Mortality in Middle-Aged and Older Adults Overall Survival (All-cause Mortality) | — | 2026-04-01 |
| Recruiting | Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatm Advanced Clear Cell Renal Cell Carcinoma, Advanced Sarcomatoid Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma | Phase 1 | 2026-04-01 |
| Recruiting | L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | EARLY_Phase 1 | 2026-04-01 |
| Recruiting | Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Met Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Carcinoma in the Liver | Phase 2 | 2026-04-01 |
| Recruiting | Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane Chemotherapy Prostate Carcinoma | N/A | 2026-04-01 |
| Recruiting | A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil Type 1 Diabetes, New Onset | Phase 1 / Phase 2 | 2026-03-30 |
| Suspended | Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopo Hematopoietic and Lymphatic System Neoplasm | Phase 1 | 2026-03-09 |
| Recruiting | 177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 1 | 2026-03-05 |
| Not Yet Recruiting | Autologous CD6-CAR Treg Cells for Patients With Stage 3 Type 1 Diabetes Stage 3 Type 1 Diabetes | EARLY_Phase 1 | 2026-03-01 |
| Recruiting | Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Sta Hearing Loss, Metastatic Malignant Germ Cell Tumor, Metastatic Malignant Nongerminomatous Germ Cell Tumor | Phase 1 | 2026-02-19 |
| Recruiting | Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma Recurrent Diffuse Large B-Cell Lymphoma, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | Phase 2 | 2026-02-11 |
| Recruiting | Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minoritie Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma | Phase 1 | 2026-02-07 |
| Recruiting | Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Car Prostate Carcinoma, Recurrent Prostate Carcinoma | Phase 2 | 2026-01-23 |
| Recruiting | A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Me Multiple Myeloma | — | 2026-01-21 |
| Recruiting | Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therap Hematologic Malignancies | Phase 3 | 2026-01-14 |
| Recruiting | Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemi Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 2 | 2026-01-07 |
| Withdrawn | STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Col Locally Advanced Cervical Carcinoma, Locally Advanced Colorectal Carcinoma, Locally Advanced Malignant Solid Neoplasm | Phase 1 | 2025-12-05 |
| Recruiting | Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directe Prostate Cancer | Phase 2 | 2025-11-26 |
| Recruiting | Nab-Paclitaxel PIPAC in Combination With Paclitaxel and Ramucirumab for the Treatment of Stomach Cancer With P Clinical Stage IVB Gastric Cancer AJCC v8, Metastatic Gastric Adenocarcinoma, Metastatic Malignant Neoplasm in the Peritoneum | Phase 1 | 2025-10-29 |
| Recruiting | MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia | Phase 1 | 2025-10-24 |
| Recruiting | Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Lymphoblastic Lymphoma | Phase 2 | 2025-10-10 |
| Recruiting | Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer S Breast Carcinoma, Chemotherapy-Induced Peripheral Neuropathy, Colon Carcinoma | Phase 2 | 2025-10-03 |
| Recruiting | External Beam Radiation Therapy in Combination With Talquetamab for the Treatment of Multiple Myeloma Patients Extramedullary Disease in Multiple Myeloma, Multiple Myeloma | Phase 1 / Phase 2 | 2025-08-29 |
| Recruiting | Different Types of Massage Therapy to Reduce Anxiety During Chemotherapy Infusion in Patients With Cancer Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | N/A | 2025-08-28 |
| Recruiting | Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | Phase 2 | 2025-08-28 |
| Recruiting | Zanubrutinib in Combination With Odronextamab for the Treatment of Patients With Richter's Transformation Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia, Richter Syndrome | Phase 1 | 2025-08-14 |
| Withdrawn | Indocyanine Green Fluoroscopy and SPY Angiography for the Assessment of Lymphatic Structure in Breast Cancer P Breast Cancer-Related Lymphedema, Breast Carcinoma | N/A | 2025-08-14 |
| Recruiting | Glofitamab With Obinutuzumab Pre-treatment for the Treatment of Central Nervous System Lymphoma Primary Central Nervous System Lymphoma, Secondary Central Nervous System Lymphoma | Phase 1 | 2025-07-30 |
| Suspended | A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia | Phase 1 | 2025-07-30 |
| Recruiting | Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colore Resectable Colorectal Carcinoma, Stage II Colorectal Cancer AJCC v8, Stage III Colorectal Cancer AJCC v8 | N/A | 2025-07-12 |
| Recruiting | Aromatherapy Essential Oils to Manage Anxiety and Nausea in Cancer Patients Receiving Infusion in the Ambulato Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | N/A | 2025-07-08 |
| Recruiting | 225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 1 | 2025-07-01 |
| Recruiting | Virtual Reality Interventions for the Improvement of Depression, Anxiety and Pain in Patients With Head and Ne Head and Neck Carcinoma | N/A | 2025-06-25 |
| Recruiting | Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent o Recurrent Astrocytoma, IDH-Mutant, Grade 3, Recurrent Astrocytoma, IDH-Mutant, Grade 4, Recurrent Glioblastoma | Phase 1 | 2025-06-17 |
| Recruiting | Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoieti Acute Lymphoblastic Leukemia | EARLY_Phase 1 | 2025-06-09 |
| Withdrawn | Multi-antigen Specific CD8+ T Cells With Decitabine and Lymphodepleting Chemotherapy for the Treatment of Pati Recurrent Acute Myeloid Leukemia, Recurrent Myelodysplastic Syndrome, Refractory Acute Myeloid Leukemia | Phase 1 | 2025-06-07 |
| Recruiting | Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Meta Breast Carcinoma, Colorectal Carcinoma | Phase 1 | 2025-05-27 |
| Suspended | Regorafenib in Combination With Venetoclax and Azacitidine for the Treatment of Patients With Relapsed or Refr Myelodysplastic Syndrome/Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Recurrent Myelodysplastic Syndrome | Phase 1 | 2025-05-21 |
| Recruiting | FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery Rectal Adenocarcinoma, Stage IIA Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8 | Phase 2 | 2025-05-20 |
| Recruiting | Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non- Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Lung Non-Small Cell Carcinoma | Phase 2 | 2025-05-05 |
| Withdrawn | Niraparib and Selenium for the Treatment of Recurrent BRCA Negative Platinum Resistant Ovarian Cancer Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma | Phase 1 / Phase 2 | 2025-04-18 |
| Recruiting | Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Vers Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia | Phase 2 | 2025-04-18 |
| Withdrawn | Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Brain, Stage IV Lung Cancer AJCC v8 | Phase 2 | 2025-04-15 |
| Recruiting | Papaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE Locally Advanced Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8 | Phase 1 | 2025-04-07 |
| Recruiting | [18F]-rhPSMA PET-CT Imaging Performance in Patients With Prostate Cancer Prostate Carcinoma | N/A | 2025-03-25 |
| Suspended | Epcoritamab and Tazemetostat for the Treatment of Relapsed or Refractory Grade I-IIIa Follicular Lymphoma Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3a Follicular Lymphoma | Phase 2 | 2025-03-11 |
| Recruiting | Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Do Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 1 | 2025-01-28 |
| Recruiting | Nemtabrutinib With Rituximab for the Treatment of Patients With Mantle Cell Lymphoma Mantle Cell Lymphoma | Phase 2 | 2025-01-22 |
| Recruiting | Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell T Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome | Phase 1 | 2025-01-17 |
| Recruiting | An Exosomal microRNA Signature for Preoperative Staging in Colon Cancer Colon Cancer | — | 2025-01-15 |
| Recruiting | Integrated Cf-miRNA and Exosomal miRNA Signature for Early Detection of Esophageal Squamous Cell Carcinoma ESCC | — | 2025-01-15 |
| Recruiting | Detection of Minimal Residual Disease Using Exosomal miRNA Distant Metastasis Markers Gastric Cancer | — | 2025-01-15 |
| Recruiting | Liquid Biopsy for Early Detection of Colorectal Cancer Using Circular RNA Colorectal Cancer | — | 2025-01-15 |
| Recruiting | A Cell-free tsRNA Signature for Early Detection of Hepatocellular Carcinoma Hepatocellular Carcinoma (HCC) | — | 2025-01-15 |
| Recruiting | Telehealth Intervention for Ostomy Self-Management Colorectal Cancer, Bladder Cancer | Phase 2 | 2025-01-02 |
| Recruiting | CMV-specific HIV-CAR T Cells as Immunotherapy for HIV/AIDS HIV-1 | EARLY_Phase 1 | 2024-12-19 |
| Recruiting | Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemother Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | Phase 3 | 2024-12-16 |
| Recruiting | A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungo Recurrent Mycosis Fungoides, Recurrent Sezary Syndrome, Refractory Mycosis Fungoides | — | 2024-12-06 |
| Recruiting | Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant Acute Leukemia, Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia | Phase 1 | 2024-12-06 |
| Recruiting | Acalabrutinib, Obinutuzumab, and Glofitamab for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma Mantle Cell Lymphoma | Phase 2 | 2024-12-02 |
| Withdrawn | Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients with Glioblastoma Glioblastoma, Malignant Glioma | Phase 1 | 2024-11-15 |
| Recruiting | A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Recurrent Severe Aplastic Anemia, Refractory Severe Aplastic Anemia | Phase 1 | 2024-11-15 |
| Recruiting | Prediction of Neoadjuvant Chemotherapy Response in Pancreatic Cancer Pancreatic Ductal Adenocarcinoma | — | 2024-11-15 |
| Recruiting | Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Po Recurrent Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia | Phase 1 | 2024-11-06 |
| Withdrawn | Botensilimab, Balstilimab and Regorafenib or Botensilimab and Balstilimab for the Treatment of Advanced or Met Advanced Colon Adenocarcinoma, Advanced Colorectal Adenocarcinoma, Advanced Rectal Adenocarcinoma | Phase 2 | 2024-11-01 |
| Withdrawn | Magrolimab in Combination with Azacitidine After Allogeneic HCTin Treating Patients with High-Risk AML or MDS Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 1 | 2024-10-09 |
| Recruiting | Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | Phase 2 | 2024-10-09 |
| Active Not Recruiting | On the BRINK: PhotoBiomodulation (PBM) for Mucositis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | — | 2024-10-07 |
| Recruiting | Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and The Metastatic Pancreatic Adenocarcinoma | N/A | 2024-10-07 |
| Recruiting | Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | Phase 2 | 2024-09-16 |
| Recruiting | Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Fol Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3a Follicular Lymphoma | Phase 2 | 2024-09-09 |
| Recruiting | Denosumab for Type 1 Diabetes Type 1 Diabetes | Phase 1 / Phase 2 | 2024-09-03 |
| Suspended | High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breas Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 2 | 2024-08-26 |
| Suspended | Aromatherapy Oil Associated for Managing Anxiety and Pain During Bone Marrow Biopsy Procedures Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | N/A | 2024-08-23 |
| Recruiting | Biology-Guided Radiation Therapy for the Treatment of Patients With Bone Metastases Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Solid Neoplasm | Phase 1 | 2024-07-26 |
| Recruiting | Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Rece Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor-Positive Breast Carcinoma, Metastatic Breast Carcinoma | Phase 2 | 2024-07-23 |
| Recruiting | PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castrat Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 1 | 2024-07-19 |
| Active Not Recruiting | e-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gyn Malignant Female Reproductive System Neoplasm, Stage III Cervical Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8 | N/A | 2024-07-19 |
| Recruiting | Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 2 | 2024-07-16 |
| Recruiting | Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With Thyroid Gland Follicular Carcinoma, Thyroid Gland Oncocytic Carcinoma, Thyroid Gland Papillary Carcinoma | Phase 2 | 2024-07-15 |
| Recruiting | CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Pat Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia | Phase 2 | 2024-07-12 |
| Recruiting | Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patie Advanced Prostate Carcinoma, Metastatic Prostate Carcinoma, Prostate Carcinoma | Phase 2 | 2024-07-09 |
| Withdrawn | Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Breast Carcinoma, Chemotherapy-Induced Peripheral Neuropathy, Colon Carcinoma | EARLY_Phase 1 | 2024-07-06 |
| Withdrawn | Electron Beam Radiotherapy for the Treatment of Refractory Sclerodermatous Chronic Graft Versus Host Disease Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm, Refractory Sclerodermatous Graft Versus Host Disease | EARLY_Phase 1 | 2024-06-30 |
| Recruiting | Risk Assessment Evaluation for Identifying Participants at High Risk for Stomach Cancer Gastric Carcinoma | N/A | 2024-06-27 |
| Recruiting | Development of a cfDNA 5mC/5hmC-based Biomarker Panel to Predict Targeted Therapy Efficacy in mCRC CRC (Colorectal Cancer) | — | 2024-06-21 |
| Completed | Forecasting Occult liveR Metastasis Using an Exosomal Signature for Intelligent Guided Hepatic Targeting PDAC - Pancreatic Ductal Adenocarcinoma | — | 2024-06-21 |
| Completed | Liquid Biopsy Using Exosomal miRNA Enables Risk Stratification of Potential Metastasis in Patients With Intrah Intrahepatic Cholangiocarcinoma (Icc) | — | 2024-06-21 |
| Recruiting | Splicing-based Predictive Learning for Individual Chemotherapy Evaluation in Colorectal Cancer Colorectal Cancer, Colorectal Cancer Recurrent, Colorectal Cancer Stage II | — | 2024-06-21 |
| Recruiting | cfDNA 5mC/5hmC Biomarkers to Predict Chemotherapy Response in Metastatic Colorectal Cancer CRC (Colorectal Cancer) | — | 2024-06-21 |
| Active Not Recruiting | Epigenetic Signature for CRC Early Detection Colorectal Cancer (Diagnosis), Non-cancer Controls, DNA Methylation | — | 2024-06-21 |
| Recruiting | A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer Hepatocellular Carcinoma (HCC), Cholangiocarcinoma, Pancreatic Ductal Adenocarcinoma (PDAC) | — | 2024-06-21 |
| Completed | An Exosomal miRNA-based Liquid Biopsy for ICC Detection Intrahepatic Cholangiocarcinoma (Icc) | — | 2024-06-21 |
| Recruiting | Comparing the Impact of Four Types of Meditation Practices for Relaxation in Cancer Survivors Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | N/A | 2024-06-17 |
| Recruiting | Exosome-derived Extrahepatic Metastasis Detection By Liquid Biopsy In Colorectal Cancer Liver Metastases Colorectal Cancer Liver Metastases (CRLM), Metastatic Colorectal Carcinoma (mCRC) | — | 2024-06-01 |
| Recruiting | Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leu Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 1 | 2024-05-24 |
| Recruiting | Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving C Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 | N/A | 2024-05-21 |
| Recruiting | Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer Advanced Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 | Phase 1 | 2024-05-13 |
| Recruiting | The da Vinci Single Port Robotic System for Use in Abdominal and Pelvic Surgical Procedures Disease or Disorder | Phase 2 | 2024-04-26 |
| Recruiting | Carfilzomib in Combination With Sotorasib for the Treatment of Patients With KRAS G12C Mutated Advanced or Met Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 | Phase 1 | 2024-04-24 |
| Active Not Recruiting | Passive Music Intervention for the Reduction of Anxiety in Patients Undergoing Bone Marrow Aspiration and/or B Hematopoietic and Lymphoid System Neoplasm | Phase 3 | 2024-04-22 |
| Recruiting | Mezigdomide (CC-92480) Post Idecabtagene Vicleucel in Treating Patients With Relapsed Multiple Myeloma Multiple Myeloma | Phase 1 | 2024-04-09 |
| Recruiting | An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Cholangiocarcinoma | — | 2024-03-15 |
| Suspended | Allogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells (CD6-CAR Tregs) for the Treatment of Patients With Chronic Graft Versus Host Disease, Hematologic and Lymphocytic Disorder, Steroid Refractory Graft Versus Host Disease | Phase 1 | 2024-02-19 |
| Suspended | Lenalidomide and Epcoritamab for the Treatment of Previously Untreated Follicular Lymphoma Follicular Lymphoma | Phase 2 | 2024-01-24 |
| Recruiting | Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymp Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Grade 3b Follicular Lymphoma, Recurrent High Grade B-Cell Lymphoma | Phase 2 | 2024-01-02 |
| Recruiting | CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia Acute Myeloid Leukemia, Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia | Phase 1 | 2023-12-07 |
| Recruiting | Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Lung Carcinoma | N/A | 2023-12-05 |
| Recruiting | Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogre Lung Non-Small Cell Carcinoma, Malignant Solid Neoplasm, Melanoma | Phase 2 | 2023-11-29 |
| Active Not Recruiting | Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell C Clear Cell Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 | Phase 1 | 2023-10-06 |
| Suspended | Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation for Improved Breast Appearance Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Estrogen Receptor-Positive Breast Carcinoma | Phase 2 | 2023-09-29 |
| Recruiting | Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) for the Treatmen High Grade B-Cell Non-Hodgkin's Lymphoma, Intermediate Grade B-Cell Non-Hodgkin's Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma | Phase 1 | 2023-09-29 |
| Withdrawn | 64Cu-DOTA Pembrolizumab for Imaging Metastatic Solid Tumors in Patients Receiving Stereotactic Body Radiation Metastatic Malignant Solid Neoplasm | EARLY_Phase 1 | 2023-08-25 |
| Recruiting | Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29 Cutaneous Lymphoma | — | 2023-08-17 |
| Recruiting | Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed Blastoid Variant Mantle Cell Lymphoma, Mantle Cell Lymphoma, Pleomorphic Variant Mantle Cell Lymphoma | Phase 1 / Phase 2 | 2023-08-10 |
| Recruiting | A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia, COVID-19 Infection | Phase 2 | 2023-08-01 |
| Recruiting | Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem C B-Cell Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma, Mantle Cell Lymphoma | Phase 1 | 2023-08-01 |
| Recruiting | Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S Tri Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm | N/A | 2023-07-24 |
| Recruiting | Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractor Recurrent Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma | EARLY_Phase 1 | 2023-07-20 |
| Recruiting | Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/Mem T-lym Central Nervous System Lymphoma | Phase 1 | 2023-06-29 |
| Recruiting | Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 6 B-Cell Non-Hodgkin Lymphoma, Multiple Myeloma | Phase 2 | 2023-06-23 |
| Recruiting | Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Acute Graft Versus Host Disease, Hematopoietic and Lymphoid System Neoplasm | Phase 1 | 2023-06-16 |
| Recruiting | Lisocabtagene Maraleucel, Nivolumab and Ibrutinib for the Treatment of Richter's Transformation Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia, Richter Syndrome | Phase 2 | 2023-06-02 |
| Completed | Impact of the Therapeutic Alliance on Reduction of Disparities in Latino End-of-Life Cancer Care Cancer | — | 2023-05-19 |
| Active Not Recruiting | Tafasitamab and Zanubrutinib for the Treatment of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia o Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 2 | 2023-05-18 |
| Recruiting | Phase II Trial of Lung Chemoemobolization Lung Non-Small Cell Carcinoma, Mediastinal Neoplasm, Pleural Neoplasm | Phase 2 | 2023-05-12 |
| Active Not Recruiting | Botensilimab, Balstilimab and Regorafenib for the Treatment of Patients With Microsatellite Stable Metastatic Advanced Colorectal Adenocarcinoma, Advanced Microsatellite Stable Colorectal Carcinoma, Metastatic Colorectal Adenocarcinoma | Phase 1 / Phase 2 | 2023-05-11 |
| Active Not Recruiting | FOLFOX and Bevacizumab in Combination With Botensilimab and Balstilimab (3B-FOLFOX) for the Treatment of Micro Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma | Phase 1 / Phase 2 | 2023-05-03 |
| Suspended | Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recur Currently Only Enrolling Glioblastoma Patients at First Recurrence | Phase 1 | 2023-05-02 |
| Withdrawn | Tazemetostat in Combination With Umbralisib and Ublituximab for the Treatment Relapsed or Refractory Follicula Recurrent Follicular Lymphoma, Refractory Follicular Lymphoma | Phase 1 / Phase 2 | 2023-05-01 |
| Recruiting | Spatiotemporal Stereotactic Body Radiation Therapy for the Treatment of Patients With Polymetastatic Solid Tum Metastatic Malignant Solid Neoplasm | N/A | 2023-04-27 |
| Active Not Recruiting | CD19-Car T Cell Therapy for the Treatment of Older Adults With Acute Lymphoblastic Leukemia in First Remission B Acute Lymphoblastic Leukemia | Phase 1 | 2023-04-26 |
| Completed | Early-Onset Colorectal Cancer Recurrence Colorectal Cancer Recurrent, Colorectal Cancer, Colorectal Neoplasms | — | 2023-04-15 |
| Completed | Detecting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma (LyMIC) Cholangiocarcinoma, Cholangiocarcinoma, Intrahepatic, Cholangiocarcinoma Resectable | — | 2023-04-15 |
| Completed | A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma Esophagus Cancer, Esophageal Cancer Stage, Esophageal Cancer | — | 2023-04-15 |
| Recruiting | Early Onset Colorectal Cancer Detection Colorectal Cancer, Colorectal Neoplasms, Colorectal Adenocarcinoma | — | 2023-04-15 |
| Completed | Exosome-based Detection of Molecular Residual Disease in Stage II-III Colorectal Cancer Colo-rectal Cancer, Colorectal Cancer Recurrent | — | 2023-04-01 |
| Completed | Stomach Cancer Exosome-based Detection Gastric Cancer, Gastric Adenocarcinoma, Gastric Cancer Stage | — | 2023-03-15 |
| Suspended | RefleXion PET/CT Imaging Performance in Patients With Various Malignancies Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm | N/A | 2023-03-15 |
| Recruiting | Stage II/III Colorectal Cancer Recurrence Colorectal Cancer, Colorectal Adenocarcinoma, Colorectal Cancer Stage II | — | 2023-03-15 |
| Completed | Predicting Local and Distant Recurrence in T1 Colorectal Cancer Colorectal Cancer, Colorectal Neoplasms, Colorectal Adenocarcinoma | — | 2023-03-15 |
| Recruiting | Pancreatic Cancer Detection Consortium Pancreatic Cancer, Pancreatic Carcinoma, Pancreatic Adenocarcinoma | — | 2023-03-15 |
| Active Not Recruiting | A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | N/A | 2023-02-16 |
| Recruiting | Provider-Mediated Communication of Genetic Testing Results to At-Risk Relatives of Cancer Patients to Improve Hematopoietic and Lymphoid System Neoplasm, Hereditary Malignant Neoplasm, Malignant Solid Neoplasm | N/A | 2023-02-14 |
| Recruiting | Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Localized Prostate Carcinoma, Locally Advanced Cervical Carcinoma, Locally Advanced Rectal Carcinoma | Phase 2 | 2023-01-20 |
| Recruiting | An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brai Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Malignant Neoplasm in the Brain | Phase 4 | 2022-12-21 |
| Recruiting | 8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia | Phase 1 | 2022-12-15 |
| Withdrawn | Portable Scalp Cooling System for the Improvement of Chemotherapy-Induced Hair Loss in Patients With Metastati Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma | N/A | 2022-12-14 |
| Recruiting | Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary C Bladder Carcinoma, Genitourinary System Neoplasm, Kidney Carcinoma | N/A | 2022-11-29 |
| Active Not Recruiting | Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patien Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia | Phase 2 | 2022-11-23 |
| Recruiting | Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma | Phase 1 | 2022-11-22 |
| Active Not Recruiting | Enasidenib in Combination With Cobimetinib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia | Phase 1 | 2022-11-03 |
| Recruiting | Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma Folliculotropic Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome | Phase 2 | 2022-10-19 |
| Recruiting | Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the T Distal Bile Duct Adenocarcinoma, Gallbladder Carcinoma, Intrahepatic Cholangiocarcinoma | Phase 1 | 2022-09-19 |
| Completed | Telehealth Exercise Intervention to Improve Cardiovascular Health in Lymphoma Survivors, TECHS Trial Hodgkin Lymphoma, Non-Hodgkin Lymphoma | N/A | 2022-09-14 |
| Recruiting | An Investigational Scan (64Cu-Labeled M5A Antibody) in Combination With SOC Chemotherapy and Radiotherapy in L Locally Advanced Rectal Carcinoma, Stage III Rectal Cancer AJCC v8, Stage IIIA Rectal Cancer AJCC v8 | EARLY_Phase 1 | 2022-08-31 |
| Active Not Recruiting | RefleXion PET/CT Imaging Performance in Patients With Prostate Cancer Prostate Carcinoma | N/A | 2022-08-29 |
| Withdrawn | iConquerFear Program for the Treatment of Fear of Cancer Recurrence in Patients With Localized Renal Cell Carc Renal Cell Carcinoma | — | 2022-08-20 |
| Withdrawn | 64Cu-DOTA-pembrolizumab PET for the Study of PD1 Expression Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | Phase 1 | 2022-08-15 |
| Recruiting | AOH1996 for the Treatment of Refractory Solid Tumors Refractory Malignant Solid Neoplasm, Osteosarcoma, Leiomyosarcomas | Phase 1 | 2022-08-12 |
| Active Not Recruiting | Navitoclax, Venetoclax, and Decitabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Prev Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia | Phase 1 | 2022-07-29 |
| Recruiting | Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung Cancer Lung Carcinoma | N/A | 2022-07-29 |
| Active Not Recruiting | 90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Trea Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 1 | 2022-07-19 |
| Withdrawn | Occupational Therapy Fatigue Management-Based Intervention for Metastatic Renal Cell Carcinoma Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 | N/A | 2022-07-15 |
| Active Not Recruiting | TMLI and Alemtuzumab for Treatment of Sickle Cell Disease Sickle Cell Disease | Phase 1 | 2022-07-13 |
| Withdrawn | Effects of Ribociclib and Palbociclib on Tumor and Blood Characteristics in Patients With Metastatic Breast Ca Advanced Breast Adenocarcinoma, Advanced HER2-Negative Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8 | N/A | 2022-07-03 |
| Active Not Recruiting | A Mobile Application, Oncpatient, to Assist Patients Undergoing Radiation Therapy Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | N/A | 2022-06-29 |
| Active Not Recruiting | Copanlisib and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma | Phase 1 / Phase 2 | 2022-06-29 |
| Withdrawn | Glasdegib-Based Treatment Combinations for the Treatment of Patients With Relapsed Acute Myeloid Leukemia Who Recurrent Acute Myeloid Leukemia | Phase 1 | 2022-06-25 |
| Active Not Recruiting | The Effect of Exercise and Nicotinamide Riboside Muscle Health and Insulin Resistance in Survivors of Childhoo Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Prediabetes | N/A | 2022-06-23 |
| Active Not Recruiting | Reproducibility and Accuracy of a Portable System for Early Detection of Cardiac Dysfunction in Childhood Canc Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | N/A | 2022-06-22 |
| Active Not Recruiting | Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma | Phase 1 | 2022-06-21 |
| Recruiting | Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR Metastatic Malignant Solid Neoplasm, Lymphoma | Phase 1 | 2022-06-20 |
| Active Not Recruiting | An Immunotherapy Vaccine (PIpepTolDC) for the Treatment of Patients With Type 1 Diabetes Type 1 Diabetes Mellitus | Phase 1 | 2022-06-16 |
| Withdrawn | Diabetes Prevention Program (METFIT) in Reducing Insulin Resistance in Stage I-III Breast Cancer Survivors Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 | N/A | 2022-06-15 |
| Recruiting | Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metasta Advanced Cancer, Metastatic Cancer | Phase 1 | 2022-06-02 |
| Active Not Recruiting | Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm | EARLY_Phase 1 | 2022-05-20 |
| Recruiting | Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ova Platinum-Resistant Ovarian Carcinoma | Phase 1 | 2022-05-05 |
| Recruiting | Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutane Locally Advanced Skin Squamous Cell Carcinoma, Resectable Skin Squamous Cell Carcinoma, Unresectable Skin Squamous Cell Carcinoma | Phase 1 | 2022-04-19 |
| Active Not Recruiting | Low Dose Versus Standard Dose Dexamethasone for Reduction of Swelling in Patients with Primary or Metastatic B Malignant Brain Neoplasm, Metastatic Malignant Neoplasm in the Brain, Recurrent Malignant Brain Neoplasm | Phase 2 | 2022-04-09 |
| Recruiting | Circulating Biomarkers in the Development of Type 1 Diabetes Diabetes | — | 2022-03-29 |
| Recruiting | Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Le B Acute Lymphoblastic Leukemia, Ph-Like Acute Lymphoblastic Leukemia | Phase 1 | 2022-03-17 |
| Active Not Recruiting | Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-Americ Smoldering Plasma Cell Myeloma | Phase 2 | 2022-03-07 |
| Active Not Recruiting | Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer Advanced Lung Non-Small Cell Carcinoma, Locally Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 | Phase 1 | 2022-03-07 |
| Recruiting | TBI Using IMRT and Cyclophosphamide Prior to Stem Cell Transplant for the Treatment of Severe Systemic Scleros Systemic Scleroderma | EARLY_Phase 1 | 2022-02-24 |
| Active Not Recruiting | Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8 | Phase 2 | 2022-01-25 |
| Active Not Recruiting | CC-486 and Nivolumab for the Treatment of Hodgkin Lymphoma Refractory to PD-1 Therapy or Relapsed Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma | Phase 1 | 2022-01-03 |
| Active Not Recruiting | HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics Breast Carcinoma, Colorectal Carcinoma, Lung Carcinoma | N/A | 2021-12-30 |
| Recruiting | Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lym Relapsed Classic Hodgkin Lymphoma | Phase 2 | 2021-11-12 |
| Completed | 64 Cu-DOTA-alendronate PET Imaging in Localizing and Characterizing Breast Calcifications in Participants Befo Breast Carcinoma, Calcification | EARLY_Phase 1 | 2021-11-03 |
| Recruiting | Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatmen Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma | Phase 2 | 2021-11-02 |
| Active Not Recruiting | CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cance Advanced Clear Cell Renal Cell Carcinoma, Advanced Papillary Renal Cell Carcinoma, Advanced Renal Cell Carcinoma | Phase 1 | 2021-11-01 |
| Withdrawn | Perception of Cure Among Patients With Metastatic Cancer Hematopoietic and Lymphoid Cell Neoplasm, Metastatic Malignant Solid Neoplasm | — | 2021-10-30 |
| Recruiting | Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules Thyroid Gland Carcinoma | N/A | 2021-10-22 |
| Active Not Recruiting | Perioperative Telemonitoring to Optimize Cancer Care and Outcomes Malignant Digestive System Neoplasm | N/A | 2021-10-19 |
| Active Not Recruiting | CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 | Phase 1 | 2021-10-18 |
| Completed | Telehealth Exercise Intervention to Improve Physical Function and Frailty in Multiple Myeloma Survivors Plasma Cell Myeloma | N/A | 2021-10-06 |
| Recruiting | Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8, Unresectable Pancreatic Carcinoma | Phase 1 | 2021-09-01 |
| Active Not Recruiting | App-Based Mindfulness Intervention for the Improvement of Quality of Life in Patients With Metastatic Renal Ce Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 | N/A | 2021-08-23 |
| Active Not Recruiting | Durvalumab and Tremelimumab After Radioembolization for the Treatment of Unresectable, Locally Advanced Liver BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma | Phase 1 | 2021-08-03 |
| Withdrawn | CpG-STAT3 siRNA CAS3/SS3 and Localized Radiation Therapy for the Treatment of Relapsed/Refractory B-Cell NHL Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma | Phase 1 | 2021-07-27 |
| Recruiting | Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer Breast Carcinoma | N/A | 2021-07-27 |
| Completed | Cancer Pain Rehabilitation Program to Reduce Pain Related Distress, and Reliance of Pain Medication Through Mu Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | N/A | 2021-07-21 |
| Recruiting | Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancre Advanced Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage IIA Pancreatic Cancer AJCC v8 | Phase 2 | 2021-07-21 |
| Completed | Telehealth Exercise Platform to Reduce Frailty After Bone Marrow Transplant Hematopoietic and Lymphoid Cell Neoplasm | N/A | 2021-07-12 |
| Completed | Lung Cancer Risk Assessment and Etiology Lung Carcinoma | — | 2021-07-02 |
| Active Not Recruiting | A Multidisciplinary Approach to Improve the Health of Older Adults With Blood Cancers After Stem Cell Transpla Hematopoietic and Lymphoid Cell Neoplasm | N/A | 2021-06-03 |
| Active Not Recruiting | LB-100, Carboplatin, Etoposide, and Atezolizumab for the Treatment of Untreated Extensive-Stage Small Cell Lun Extensive Stage Lung Small Cell Carcinoma | Phase 1 | 2021-05-28 |
| Withdrawn | Physical Activity Intervention Before and After Surgery in Older Adults With Lung Cancer and Their Family Care Caregiver, Lobectomy Patient, Lung Carcinoid Tumor | N/A | 2021-05-15 |
| Active Not Recruiting | White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Pro Prostate Adenocarcinoma, PSA Failure, PSA Progression | Phase 2 | 2021-05-10 |
| Completed | Leflunomide for the Treatment of Relapsed or Refractory CD30+ Lymphoproliferative Disorders Recurrent Lymphoproliferative Disorder, Refractory Lymphoproliferative Disorder | Phase 2 | 2021-05-05 |
| Recruiting | Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prosta Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 | Phase 2 | 2021-05-04 |
| Suspended | Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergo Allogeneic Hematopoietic Stem Cell Transplant Recipient, Hematopoietic and Lymphoid Cell Neoplasm | Phase 1 | 2021-04-30 |
| Recruiting | Study to Detect Changes in Urinary and Gut Microbiome During Androgen Deprivation Therapy and Radiation Therap Stage I Prostate Cancer AJCC v7, Stage II Prostate Cancer AJCC v7, Stage IIA Prostate Cancer AJCC v7 | — | 2021-04-14 |
| Active Not Recruiting | Acalabrutinib, Umbralisib, and Ublituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma Mantle Cell Lymphoma | Phase 2 | 2021-03-26 |
| Active Not Recruiting | Acalabrutinib for the Treatment of Relapsed or Refractory Autoimmune Hemolytic Anemia in Patients With Chronic Autoimmune Hemolytic Anemia, Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Phase 2 | 2021-03-16 |
| Completed | Microbial Diversity Between Inflamed and Non-inflamed Skin of Patients With Immune Checkpoint Inhibitor-Induce Genito-Urinary Neoplasm | N/A | 2021-03-08 |
| Active Not Recruiting | A Nurse-Led Intervention for Fear of Progression in Advanced Cancer Advanced Lung Carcinoma, Metastatic Malignant Female Reproductive System Neoplasm, Stage III Lung Cancer AJCC v8 | N/A | 2021-03-08 |
| Active Not Recruiting | Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, Glioblastoma, Medulloblastoma | Phase 1 | 2021-03-05 |
| Active Not Recruiting | Home Base Telemonitoring in Gastrointestinal, Genitourinary, or Gynecologic Cancer Patients Undergoing Abdomin Digestive System Carcinoma, Genitourinary System Carcinoma, Malignant Female Reproductive System Neoplasm | N/A | 2021-02-16 |
| Active Not Recruiting | Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy Diffuse Large B-Cell Lymphoma Unclassifiable, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma | Phase 2 | 2021-01-18 |
| Completed | Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Symptomatic COVID-19 Infection Laboratory-Confirmed | Phase 1 / Phase 2 | 2021-01-07 |
| Recruiting | Modified Immune Cells (CD19 CAR T Cells) and Acalabrutinib for the Treatment of Relapsed or Refractory Mantle Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma | Phase 2 | 2020-12-31 |
| Recruiting | CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors i Malignant Brain Neoplasm, Recurrent Malignant Brain Neoplasm, Refractory Malignant Brain Neoplasm | Phase 1 | 2020-12-04 |
| Recruiting | Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma | Phase 2 | 2020-11-27 |
| Active Not Recruiting | Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Hematopoietic and Lymphoid Cell Neoplasm | — | 2020-11-18 |
| Completed | Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm | Phase 1 | 2020-11-18 |
| Completed | Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplas Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome | Phase 2 | 2020-11-11 |
| Active Not Recruiting | Technology-Enabled Activation of Skin Cancer Screening for Stem Cell Transplant Survivors and Their Primary Ca Skin Carcinoma | N/A | 2020-10-30 |
| Withdrawn | Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood Cancer Acute Biphenotypic Leukemia, Acute Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Phase 2 | 2020-10-20 |
| Active Not Recruiting | Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma Smoldering Plasma Cell Myeloma | EARLY_Phase 1 | 2020-10-08 |
| Completed | SARS-CoV-2 Donor-Recipient Immunity Transfer Accelerated Phase CML, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | — | 2020-09-23 |
| Recruiting | Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer BRAF NP_004324.2:p.V600E, BRAF V600K Mutation Present, Thyroid Gland Anaplastic Carcinoma | Phase 1 | 2020-09-14 |
| Recruiting | PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorecta Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IVA Gastric Cancer AJCC v8, Clinical Stage IVB Gastric Cancer AJCC v8 | Phase 1 | 2020-08-21 |
| Completed | Family Caregivers in Underserved Populations Providing Complex Cancer Care Malignant Female Reproductive System Neoplasm, Stage 0 Lung Cancer AJCC v8, Stage I Lung Cancer AJCC v8 | N/A | 2020-07-15 |
| Completed | An Imaging Agent (I-124 M5A) in Detecting CEA-Positive Liver Metastases in Patients With Colorectal Cancer Colorectal Carcinoma Metastatic in the Liver, Metastatic Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v8 | Phase 1 | 2020-07-15 |
| Active Not Recruiting | Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma Asymptomatic COVID-19 Infection Laboratory-Confirmed, Symptomatic COVID-19 Infection Laboratory-Confirmed | — | 2020-07-13 |
| Active Not Recruiting | Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer Lung Non-Small Cell Carcinoma, Stage I Colorectal Cancer AJCC v8, Stage I Lung Cancer AJCC v8 | Phase 3 | 2020-07-11 |
| Completed | Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Ma Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma, Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Phase 1 | 2020-06-08 |
| Completed | Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metast Advanced Colon Adenocarcinoma, Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma | Phase 1 | 2020-05-27 |
| Active Not Recruiting | Intermittent Duvelisib Dosing in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymp Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia | Phase 2 | 2020-05-13 |
| Active Not Recruiting | Leflunomide in Treating Patients With Steroid Dependent Chronic Graft Versus Host Disease Chronic Graft Versus Host Disease, Steroid Refractory Graft Versus Host Disease | Phase 1 | 2020-05-12 |
| Recruiting | Pembrolizumab and Decitabine With or Without Venetoclax in Treating Patients With Acute Myeloid Leukemia or My Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia | Phase 1 | 2020-05-04 |
| Recruiting | Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer. Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Carcinoma, Metastatic Breast Carcinoma | Phase 2 | 2020-03-25 |
| Recruiting | Early Detection of Advanced Adenomas and Colorectal Cancer Colorectal Cancer, Colorectal Neoplasms, Colorectal Polyp | — | 2020-03-15 |
| Active Not Recruiting | Brigatinib and Bevacizumab for the Treatment of ALK-Rearranged Locally Advanced, Metastatic, or Recurrent NSCL Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma | Phase 1 | 2020-03-09 |
| Active Not Recruiting | TBI Using IMRT (VMAT or Tomotherapy) for the Prevention of Pul Toxicities in Patients Undergoing Donor SCT Acute Leukemia, Myelodysplastic Syndrome | Phase 1 | 2020-02-28 |
| Active Not Recruiting | Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ R Recurrent Glioblastoma, Recurrent Malignant Glioma, Recurrent WHO Grade II Glioma | Phase 1 | 2020-02-26 |
| Withdrawn | Psycho-Educational Cognition Intervention in Patients With Blood and Lymph Cancer Hematopoietic and Lymphoid Cell Neoplasm | N/A | 2020-02-10 |
| Active Not Recruiting | Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Pat Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome | Phase 2 | 2020-02-07 |
| Completed | Perioperative Ostomy Self-Management Telehealth for Cancer Patients and Family Caregivers Malignant Neoplasm | Phase 2 | 2020-01-23 |
| Active Not Recruiting | Telehealth for the Self-Management of Dietary Quality of Life in Patients After Stomach Cancer Surgery Gastric Carcinoma, Gastroesophageal Junction Adenocarcinoma | N/A | 2020-01-21 |
| Active Not Recruiting | Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tis Metastatic Leiomyosarcoma, Metastatic Soft Tissue Sarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 | Phase 2 | 2020-01-14 |
| Completed | Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8, Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage 0 Gastric Cancer AJCC v8 | — | 2019-12-24 |
| Completed | 68Ga-PSMA-11 PET for the Diagnosis of Biochemically Recurrent Prostate Cancer Biochemically Recurrent Prostate Carcinoma | Phase 1 | 2019-12-12 |
| Withdrawn | Leflunomide in Treating Patients With High-Risk Smoldering Multiple Myeloma Smoldering Plasma Cell Myeloma | Phase 2 | 2019-12-11 |
| Recruiting | IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM Recurrent Glioblastoma, Refractory Glioblastoma | Phase 1 | 2019-12-02 |
| Active Not Recruiting | Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 2 | 2019-11-27 |
| Active Not Recruiting | PSCA-CAR T Cells in Treating Patients With PSCA+ Metastatic Castration Resistant Prostate Cancer Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 | Phase 1 | 2019-08-20 |
| Active Not Recruiting | Pembrolizumab and Blinatumomab in Treating Participants With Recurrent or Refractory Acute Lymphoblastic Leuke CD19 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | 2019-08-02 |
| Active Not Recruiting | Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma Plasma Cell Myeloma, Secondary Amyloidosis | Phase 2 | 2019-07-17 |
| Recruiting | Enasidenib (AG-221) Maintenance Post Allogeneic HCT in Patients With IDH2 Mutation Acute Myeloid Leukemia | Phase 2 | 2019-07-11 |
| Recruiting | Improving Islet Transplantation Outcomes With Gastrin for Type I Diabetes Diabetes Mellitus, Type 1 | Phase 1 / Phase 2 | 2019-07-07 |
| Completed | CBM588, Nivolumab, and Ipilimumab in Treating Patients With Stage IV or Advanced Kidney Cancer Advanced Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma | Phase 1 | 2019-05-14 |
| Recruiting | CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Multipl Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma | Phase 1 | 2019-04-23 |
| Completed | IRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Ga Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IVA Gastric Cancer AJCC v8 | Phase 1 / Phase 2 | 2019-04-19 |
| Completed | Remotivation Process for Improving Adherence to Lymphedema Treatment Programs in Patients With Breast Cancer-R Breast Carcinoma, Lymphedema | N/A | 2019-04-19 |
| Active Not Recruiting | CBM588 in Improving Clinical Outcomes in Patients Who Have Undergone Donor Hematopoietic Stem Cell Transplant Hematopoietic and Lymphoid Cell Neoplasm | Phase 1 | 2019-04-18 |
| Completed | Geriatric and Quality of Life Assessments in Older Patients With Non-metastatic or Metastatic Head and Neck or Caregiver, Head and Neck Carcinoma, Lung Carcinoma | — | 2019-03-08 |
| Completed | Ipatasertib in Combination With Carboplatin, Carboplatin/Paclitaxel, or Capecitabine/Atezolizumab in Treating Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 | Phase 1 / Phase 2 | 2019-03-04 |
| Active Not Recruiting | Curcumin in Reducing Joint Pain in Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint Disease Breast Cancer, Joint Pain | N/A | 2019-03-04 |
| Withdrawn | Brentuximab Vedotin and Lenalidomide in Treating Patients With Relapsed or Refractory T-Cell Lymphomas CD30-Positive Neoplastic Cells Present, Folliculotropic Mycosis Fungoides, Recurrent Mycosis Fungoides | Phase 1 | 2019-03-01 |
| Active Not Recruiting | Copanlisib and Nivolumab in Treating Patients With Richter's Transformation or Transformed Indolent Non-Hodgki Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma | Phase 1 | 2019-02-26 |
| Active Not Recruiting | IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver Recurrent Hepatocellular Carcinoma, Refractory Liver Carcinoma, Stage IV Hepatocellular Carcinoma AJCC v8 | Phase 1 | 2019-02-21 |
| Active Not Recruiting | Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas Anaplastic Large Cell Lymphoma, Nodal Peripheral T-Cell Lymphoma With TFH Phenotype, Recurrent Anaplastic Large Cell Lymphoma | Phase 1 / Phase 2 | 2019-02-04 |
| Active Not Recruiting | Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hyster Atypical Endometrial Hyperplasia, Endometrial Carcinoma | Phase 2 | 2019-01-21 |
| Active Not Recruiting | A Blood Stem Cell Transplant for Sickle Cell Disease Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies | Phase 1 | 2019-01-04 |
| Withdrawn | Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant Hematopoietic and Lymphoid Cell Neoplasm, Hematopoietic Cell Transplantation Recipient | Phase 1 | 2018-12-30 |
| Recruiting | Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma Mantle Cell Lymphoma | Phase 1 / Phase 2 | 2018-12-24 |
| Withdrawn | Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Bloo Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission | Phase 2 | 2018-12-01 |
| Withdrawn | ALCMI-005: Pembrolizumab and Epacadostat in Treating Patients With Extensive Stage Small Cell Lung Cancer Extensive Stage Small Cell Lung Carcinoma | Phase 2 | 2018-12-01 |
| Active Not Recruiting | Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma Ann Arbor Stage I Hodgkin Lymphoma, Ann Arbor Stage I Mixed Cellularity Classic Hodgkin Lymphoma, Ann Arbor Stage I Nodular Sclerosis Classic Hodgkin Lymphoma | Phase 2 | 2018-11-28 |
| Completed | Conquer Fear SUPPORT Intervention in Supporting Patients With Stage III-IV Lung or Gynecologic Cancer Advanced Lung Carcinoma, Malignant Female Reproductive System Neoplasm, Stage III Lung Cancer AJCC v8 | N/A | 2018-11-15 |
| Active Not Recruiting | Blood Samples to Identify Biomarkers in Patients Treated With Cyclophosphamide After Donor Stem Cell Transplan Allogeneic Hematopoietic Stem Cell Transplant Recipient, Donor, Malignant Neoplasm | — | 2018-11-13 |
| Recruiting | Biospecimen Analysis in Detecting Chemical Concentrations in Patients With Chronic or Infectious Diseases Rece Chronic Disease, Infectious Disorder | — | 2018-11-09 |
| Active Not Recruiting | Multimedia Self-Management Intervention for Lung Cancer Surgery Family Caregivers and Patients Caregiver, Stage I Lung Cancer AJCC v7, Stage IA Lung Cancer AJCC v7 | N/A | 2018-11-06 |
| Withdrawn | Daratumumab, Bortezomib, Dexamethasone, Pegylated Liposomal Doxorubicin Hydrochloride, and Lenalidomide in Tre Plasma Cell Leukemia | Phase 1 | 2018-10-25 |
| Active Not Recruiting | Early Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric C Clinical Stage 0 Gastric Cancer AJCC v8, Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8 | — | 2018-10-11 |
| Recruiting | Predicting Peripheral Neuropathy of Paclitaxel for Gastric Cancer Gastric Cancer, Chemotherapy-induced Peripheral Neuropathy, Paclitaxel | — | 2018-10-01 |
| Completed | Predicting the Efficacy in Advanced Gastric Cancer. Gastric Cancer, Chemotherapy Effect, Paclitaxel | — | 2018-10-01 |
| Completed | Systemic Light Exposure in Preventing Frailty in Older Patients With Prostate Cancer on Hormonal Therapy Prostate Carcinoma | EARLY_Phase 1 | 2018-09-24 |
| Active Not Recruiting | Safety of Blood Stem Cell Mobilization With Plerixafor in Patients With Sickle Cell Disease Sickle Cell Disease | Phase 1 | 2018-09-19 |
| Active Not Recruiting | HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases Malignant Neoplasm, Metastatic Malignant Neoplasm in the Brain, Metastatic Malignant Neoplasm in the Leptomeninges | Phase 1 | 2018-08-31 |
| Active Not Recruiting | Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Me Prostate Adenocarcinoma | Phase 2 | 2018-08-29 |
| Completed | Venetoclax and Romidepsin in Treating Patients With Recurrent or Refractory Mature T-Cell Lymphoma Anaplastic Large Cell Lymphoma, Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Phase 2 | 2018-08-21 |
| Active Not Recruiting | CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Tran Accelerated Phase CML, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission | Phase 1 | 2018-08-20 |
| Active Not Recruiting | Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma Glioblastoma, Malignant Glioma, Recurrent Glioma | Phase 1 | 2018-08-14 |
| Suspended | Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treatin Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia | Phase 1 | 2018-07-06 |
| Withdrawn | Epacadostat and Pembrolizumab Before Surgery in Treating Participants With Stage II-III Esophageal or Gastroes Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | Phase 2 | 2018-07-01 |
| Completed | Ribociclib and Aromatase Inhibitor in Treating Older Participants With Hormone Receptor Positive Metastatic Br Estrogen Receptor and/or Progesterone Receptor Positive, HER2/Neu Negative, Stage IV Breast Cancer AJCC v6 and v7 | Phase 2 | 2018-06-14 |
| Recruiting | Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegaloviru Cytomegaloviral Infection, Hematopoietic Cell Transplant Recipient | Phase 1 / Phase 2 | 2018-05-11 |
| Completed | Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That Metastatic Colon Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Carcinoma | Phase 1 | 2018-04-11 |
| Completed | Avelumab, Utomilumab, Rituximab, Ibrutinib, and Combination Chemotherapy in Treating Patients With Relapsed or Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Mantle Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma | Phase 1 | 2018-04-02 |
| Active Not Recruiting | Pevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin Lymphoma B-Cell Prolymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Diffuse Large B-Cell Lymphoma | Phase 1 | 2018-03-22 |
| Active Not Recruiting | Eat, Move, Live Program for the Reduction of Cancer and Chronic Disease Risk in Underserved Communities Diabetes Mellitus, Obesity-Related Malignant Neoplasm | N/A | 2018-03-20 |
| Suspended | Total Marrow and Lymphoid Irradiation Before Donor Transplant and Cyclophosphamide in Treating Patients With A Acute Myeloid Leukemia | Phase 1 | 2018-03-19 |
| Completed | Copper 64Cu-DOTA-Daratumumab Positron Emission Tomography in Diagnosing Patients With Relapsed Multiple Myelom Recurrent Plasma Cell Myeloma, Plasma Cell Myeloma, Secondary Amyloidosis | Phase 1 | 2018-02-21 |
| Recruiting | Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | EARLY_Phase 1 | 2018-02-15 |
| Active Not Recruiting | High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children Wit Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Lymphoblastic Lymphoma | N/A | 2018-02-14 |
| Active Not Recruiting | Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Dis Sickle Cell Disease | Phase 1 | 2018-02-02 |
| Active Not Recruiting | P53MVA and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Ca Recurrent Platinum-Resistant Fallopian Tube Carcinoma, Recurrent Platinum-Resistant Ovarian Carcinoma, Recurrent Platinum-Resistant Primary Peritoneal Carcinoma | Phase 2 | 2018-02-01 |
| Withdrawn | Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-R Plasma Cell Leukemia in Remission, Plasma Cell Myeloma | Phase 1 / Phase 2 | 2018-01-01 |
| Completed | Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal C Adult Liver Carcinoma, Caregiver, Colorectal Carcinoma | N/A | 2017-11-09 |
| Active Not Recruiting | Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients Healthy Subject | N/A | 2017-10-13 |
| Completed | Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chr Anemia, Fatigue, Fever | Phase 1 | 2017-09-05 |
| Completed | Comic Art Creation as Supportive Care in Cancer Patients and Caregivers Caregiver, Malignant Neoplasm | N/A | 2017-08-24 |
| Active Not Recruiting | Pevonedistat and Decitabine in Treating Patients With High Risk Acute Myeloid Leukemia Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia | Phase 1 | 2017-08-21 |
| Active Not Recruiting | Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention Breast Cancer | N/A | 2017-08-09 |
| Active Not Recruiting | Novel Single Wave Assessment in Measuring Cardiac Dysfunction and Metabolic Syndrome in Patients With Cancer Malignant Neoplasm | — | 2017-07-21 |
| Active Not Recruiting | Pembrolizumab and Vorinostat in Patients With Relapsed or Refractory DLBCL, FCL or HL. Grade 3b Follicular Lymphoma, Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Classic HL, Recurrent Classic Hodgkin Lymphoma | Phase 1 | 2017-07-18 |
| Completed | Durvalumab and Tremelimumab in Treating Patients With Microsatellite Stable Metastatic Colorectal Cancer to th Metastatic Carcinoma in the Liver, MLH1 Gene Mutation, MSH6 Gene Mutation | Phase 1 | 2017-06-28 |
| Completed | Education as an Intervention of Compassion Fatigue Normal Volunteer | N/A | 2017-06-06 |
| Completed | Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Br Androgen Receptor Positive, Estrogen Receptor Negative, HER2/Neu Negative | Phase 2 | 2017-06-01 |
| Completed | High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in P Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Phase 2 | 2017-05-30 |
| Active Not Recruiting | Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lym Adult T-Cell Leukemia/Lymphoma, Anaplastic Large Cell Lymphoma, ALK-Negative, Anaplastic Large Cell Lymphoma, ALK-Positive | Phase 2 | 2017-05-25 |
| Active Not Recruiting | Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients Wi Secondary Myelofibrosis | Phase 1 | 2017-05-24 |
| Completed | Brentuximab Vedotin, Cyclosporine, and Verapamil Hydrochloride in Treating Patients With Relapsed or Refractor Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma | Phase 1 | 2017-05-03 |
| Completed | Personalized Dietary Intervention in Managing Bowel Dysfunction and Improving Quality of Life in Stage I-III R Cancer Survivor, Stage I Rectosigmoid Cancer, Stage II Rectosigmoid Cancer | N/A | 2017-04-28 |
| Active Not Recruiting | Nivolumab, Ifosfamide, Carboplatin, and Etoposide as Second-Line Therapy in Treating Patients With Refractory Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma | Phase 2 | 2017-04-24 |
| Active Not Recruiting | Nivolumab & Brentuximab Vedotin Consolidation After Autologous SCT in Patients With High-Risk Classical Hodgki Classic Hodgkin Lymphoma, Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma | Phase 2 | 2017-04-03 |
| Completed | Mirvetuximab Soravtansine and Gemcitabine Hydrochloride in Treating Patients With FRalpha-Positive Recurrent O Recurrent Breast Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma | Phase 1 | 2017-03-22 |
| Active Not Recruiting | Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripher Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides | Phase 1 / Phase 2 | 2017-03-08 |
| Completed | Extracorporeal Photopheresis and Low Dose Aldesleukin in Treating Patients With Steroid Refractory Chronic Gra Chronic Graft Versus Host Disease | Phase 2 | 2017-01-18 |
| Completed | Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer HER2 Positive Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7 | Phase 2 | 2016-12-02 |
| Withdrawn | Capecitabine and Y-90 Radioembolization in Treating Patients With Advanced Bile Duct Cancer in the Liver That Bile Duct Adenocarcinoma, Stage III Intrahepatic Cholangiocarcinoma, Stage IVA Intrahepatic Cholangiocarcinoma | Phase 1 | 2016-12-01 |
| Completed | Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Primary Myelofibrosis, Secondary Myelofibrosis | Phase 1 | 2016-11-13 |
| Completed | Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Diarrhea, Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer | N/A | 2016-11-11 |
| Completed | Pembrolizumab and Palliative Radiation Therapy in Treating Patients With Metastatic Esophagus, Stomach, or Gas Gastric Adenocarcinoma, Gastric Squamous Cell Carcinoma, Gastroesophageal Junction Adenocarcinoma | Phase 2 | 2016-10-05 |
| Active Not Recruiting | Pembrolizumab, Endocrine Therapy, and Palbociclib in Treating Postmenopausal Patients With Newly Diagnosed Met Metastatic Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7 | Phase 2 | 2016-09-30 |
| Withdrawn | An Exercise Intervention Trial to Reduce Symptoms & Improve Clinical Outcomes of Platinum-Based Treatment in O Ovarian Carcinoma | N/A | 2016-09-02 |
| Active Not Recruiting | Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breas HER2 Positive Breast Carcinoma, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer | Phase 2 | 2016-07-15 |
| Completed | Ibrutinib and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma | Phase 2 | 2016-06-20 |
| Active Not Recruiting | Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy Adult Solid Neoplasm, Bladder Carcinoma, Colon Carcinoma | Phase 1 | 2016-06-14 |
| Active Not Recruiting | RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy or For Whic Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2016-06-13 |
| Active Not Recruiting | Eat, Move, Live Intervention in Reducing Chronic Disease Risk in Medically Vulnerable Communities Healthy Subject | N/A | 2016-04-06 |
| Completed | Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative | Phase 2 | 2016-03-28 |
| Active Not Recruiting | Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected Patie HIV | Phase 1 | 2016-03-10 |
| Active Not Recruiting | Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients Wit Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma | Phase 1 | 2016-03-07 |
| Terminated | FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer Recurrent Colorectal Carcinoma, Stage IVA Colorectal Cancer, Stage IVB Colorectal Cancer | Phase 2 | 2016-02-16 |
| Active Not Recruiting | Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, an Pancreatic Adenocarcinoma, Unresectable Pancreatic Carcinoma, Stage III Pancreatic Cancer AJCC v6 and v7 | Phase 1 | 2016-01-14 |
| Completed | Pancreatic Nutritional Program for Weight Loss in Overweight/Obese Patients With Stage I-III Breast Cancer Obesity, Stage IA Breast Cancer, Stage IB Breast Cancer | N/A | 2016-01-07 |
| Active Not Recruiting | Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma AIDS-related Non-Hodgkin Lymphoma, AIDS-related Plasmablastic Lymphoma, AIDS-related Primary Effusion Lymphoma | Phase 1 | 2015-12-31 |
| Active Not Recruiting | Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia Adult Acute Myeloid Leukemia in Remission, Acute Biphenotypic Leukemia, Early Relapse of Acute Myeloid Leukemia | Phase 1 | 2015-12-15 |
| Completed | Leflunomide in Treating Patients With Relapsed or Refractory Multiple Myeloma Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma | Phase 1 / Phase 2 | 2015-12-02 |
| Completed | COMFORT Caregiver Intervention in Improving Communication and Reducing Distress in Caregivers of Patients With Caregiver | N/A | 2015-11-24 |
| Active Not Recruiting | Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma AIDS-Related Burkitt Lymphoma, AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Plasmablastic Lymphoma | Phase 1 | 2015-11-20 |
| Active Not Recruiting | Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer Breast Cancer, Colon Cancer, Extrahepatic Bile Duct Cancer | N/A | 2015-11-11 |
| Active Not Recruiting | Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV a Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission | Phase 2 | 2015-11-05 |
| Withdrawn | Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced I Acute Myeloid Leukemia in Remission, Primary Myelofibrosis, Primary Myelofibrosis, Prefibrotic Stage | Phase 1 | 2015-11-01 |
| Completed | Culturally Adapted Parenting Intervention for Spanish-Speaking Parents in Improving Outcomes of Younger Acute Cancer Survivor, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission | N/A | 2015-10-22 |
| Completed | 8-Chloroadenosine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2015-09-02 |
| Active Not Recruiting | Geriatric Assessment in Predicting Chemotherapy Toxicity and Vulnerabilities in Older Patients With Cancer Solid Neoplasm | N/A | 2015-08-04 |
| Completed | Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in P Stage I Adult Liver Cancer, Stage I Colorectal Cancer, Stage IA Gastric Cancer | N/A | 2015-07-22 |
| Completed | PatientCareAnywhere Internet-Based Software in Improving Communication and Education in Patients With Cancer a Bladder Carcinoma, Breast Carcinoma, Colorectal Carcinoma | N/A | 2015-07-07 |
| Terminated | Peer-to-Peer Support Program in Improving Quality of Life Outcomes in Patients With Gynecologic Cancer and The Cervical Carcinoma, Ovarian Carcinoma, Uterine Corpus Cancer | N/A | 2015-07-01 |
| Completed | Total Marrow and Lymphoid Irradiation and Chemotherapy Before Donor Transplant in Treating Patients With Myelo Adult Acute Lymphoblastic Leukemia in Complete Remission, Acute Myeloid Leukemia in Remission, Previously Treated Myelodysplastic Syndrome | Phase 1 | 2015-06-25 |
| Completed | Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission | Phase 2 | 2015-05-21 |
| Completed | Neuropharmacokinetics of Eribulin Mesylate in Treating Patients With Primary or Metastatic Brain Tumors Metastatic Malignant Neoplasm in the Adult Brain, Primary Brain Tumor | EARLY_Phase 1 | 2015-05-19 |
| Active Not Recruiting | Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma Recurrent Glioblastoma, Recurrent Malignant Glioma, Recurrent WHO Grade II Glioma | Phase 1 | 2015-05-18 |
| Completed | Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate Cancer Adenocarcinoma of the Prostate, Stage IIB Prostate Cancer, Stage III Prostate Cancer | Phase 1 | 2015-03-05 |
| Completed | Video-Assisted Intervention in Improving Recovery in Patients With Cancer Undergoing Lung Surgery and Caregive Malignant Lung Neoplasm | N/A | 2015-02-11 |
| Completed | Palliative Care Intervention in Improving Symptom Control and Quality of Life in Patients With Stage II-IV Non Caregiver, Psychological Impact of Cancer and Its Treatment, Recurrent Non-small Cell Lung Cancer | N/A | 2015-02-01 |
| Active Not Recruiting | Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patien Bone Metastases, HER2-positive Breast Cancer, Liver Metastases | N/A | 2015-01-07 |
| Completed | p53MVA Vaccine and Gemcitabine Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer Recurrent Ovarian Epithelial Cancer, Recurrent Fallopian Tube Carcinoma, Recurrent Primary Peritoneal Carcinoma | Phase 1 | 2015-01-01 |
| Terminated | BEAM vs. 90-Yttrium Ibritumomab Tiuxetan (Zevalin®)/BEAM With ASCT for Relapsed DLBCL Recurrent Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma | Phase 3 | 2015-01-01 |
| Withdrawn | Educational Brochure in Preparing Patients With Gastric Cancer and Their Caregivers for Recovery After Surgery Anxiety, Gastric Carcinoma, Stress | N/A | 2015-01-01 |
| Completed | Video-Based Intervention in Reducing Anxiety in Patients Undergoing Lung Cancer Screening Anxiety, No Evidence of Disease, Lung Carcinoma | N/A | 2014-12-08 |
| Withdrawn | Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian Recurrent Ovarian Epithelial Cancer, Recurrent Ovarian Germ Cell Tumor, Recurrent Pancreatic Cancer | N/A | 2014-12-01 |
| Completed | 64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric Cancer Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach, Intestinal Adenocarcinoma of the Stomach | N/A | 2014-11-19 |
| Completed | Palliative Care in Improving Quality of Life in Patients With Newly Diagnosed Pancreatic Cancer Stage IIA Pancreatic Cancer, Stage IIB Pancreatic Cancer, Stage III Pancreatic Cancer | N/A | 2014-11-01 |
| Active Not Recruiting | Cellular Immunotherapy in Treating Patients With High-Risk Acute Lymphoblastic Leukemia B Acute Lymphoblastic Leukemia, Recurrent Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia | Phase 1 | 2014-10-16 |
| Completed | Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High- Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma | Phase 1 | 2014-10-07 |
| Completed | N2-(1-carboxyethyl)-2'Deoxyguanosine (CEdG) a Potential Biomarker for Diabetes Diabetes | N/A | 2014-10-01 |
| Completed | Eribulin Mesylate and Everolimus in Treating Patients With Triple-Negative Metastatic Breast Cancer Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor-negative | Phase 1 | 2014-10-01 |
| Active Not Recruiting | Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chron B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma, B-Cell Prolymphocytic Leukemia, High Grade B-Cell Lymphoma, Not Otherwise Specified | Phase 1 | 2014-09-24 |
| Completed | Palliative Care Intervention in Improving Quality of Life, Psychological Distress, and Communication in Patien Unspecified Adult Solid Tumor, Protocol Specific | N/A | 2014-09-08 |
| Completed | Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer Survivors Cancer Survivor, Estrogen Receptor-positive Breast Cancer, Stage IA Breast Cancer | N/A | 2014-09-07 |
| Completed | Diffuse Optical Imaging With Indocyanine Green Solution in Imaging Pelvic Lymph Nodes in Patients With Stage I Stage IIA Prostate Cancer, Stage IIB Prostate Cancer | Phase 1 | 2014-07-25 |
| Withdrawn | Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liv Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Liver Metastases | Phase 1 | 2014-07-01 |
| Completed | Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Relapsed/Refractory Multipl Refractory Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma | Phase 1 / Phase 2 | 2014-06-30 |
| Active Not Recruiting | Memory Enriched T Cells Following Stem Cell Transplant in Treating Patients With Recurrent B-Cell Non-Hodgkin Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Mantle Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma | Phase 1 | 2014-06-19 |
| Completed | Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Advanced Adult Hepatocellular Carcinoma | Phase 1 | 2014-06-11 |
| Completed | MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patient Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer | Phase 1 | 2014-06-01 |
| Active Not Recruiting | Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopi FIGO Stage IVA Ovarian Cancer, FIGO Stage IVB Ovarian Cancer, Platinum-Resistant Ovarian Carcinoma | Phase 1 | 2014-05-19 |
| Active Not Recruiting | Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Phase 2 | 2014-05-12 |
| Completed | Survivorship Care Planning in Improving Quality of Life in Survivors of Ovarian Cancer Cancer Survivor, Stage IA Ovarian Epithelial Cancer, Stage IB Ovarian Epithelial Cancer | N/A | 2014-04-11 |
| Active Not Recruiting | Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Le Adult Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in Remission | Phase 2 | 2014-02-10 |
| Completed | Computed Tomography and Biomarker Analysis in Diagnosing Coronary Artery Disease in Asymptomatic Patients Who Cancer Survivor, Diabetes Mellitus, Hypertension | N/A | 2014-02-01 |
| Completed | Vaccine Therapy in Healthy Volunteers With or Without Previous Exposure to Cytomegalovirus Cytomegalovirus Infection, Healthy, no Evidence of Disease | Phase 1 | 2014-01-05 |
| Withdrawn | Short-Infusion Ziv-aflibercept in Treating Patients With Metastatic Colorectal Cancer Receiving Combination Ch Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer | N/A | 2014-01-01 |
| Completed | Fluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients With Recur Recurrent Prostate Cancer | N/A | 2013-12-01 |
| Active Not Recruiting | Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing Surgery Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer | Phase 1 | 2013-11-25 |
| Active Not Recruiting | Islet Cell Transplant for Type 1 Diabetes Type 1 Diabetes Mellitus | Phase 2 | 2013-10-16 |
| Active Not Recruiting | Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Phase 1 | 2013-10-08 |
| Completed | Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointe Healthy Subject, Localized Transitional Cell Cancer of the Renal Pelvis and Ureter, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | N/A | 2013-10-01 |
| Active Not Recruiting | Brain Functional MRI in Older Women With Breast Cancer (Brain fMRI-BC) Breast Cancer | — | 2013-09-30 |
| Terminated | Dasatinib, Cytarabine, and Idarubicin in Treating Patients With High-Risk Acute Myeloid Leukemia Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Phase 1 / Phase 2 | 2013-09-13 |
| Completed | Psycho-Educational Program in Increasing Knowledge and Satisfaction and Decreasing Distress in Younger Patient Malignant Neoplasm, Psychosocial Effects of Cancer and Its Treatment | N/A | 2013-08-01 |
| Terminated | Optimization of Novel DCE-MRI Imaging Sequences for Cancer Therapy Monitoring Normal Volunteers | — | 2013-07-23 |
| Active Not Recruiting | Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IIA Breast Cancer | Phase 2 | 2013-07-17 |
| Active Not Recruiting | Survivorship Care Planning in Improving the Quality of Life in Breast Cancer Survivors Breast Cancer, Cancer Survivor | N/A | 2013-07-15 |
| Completed | PI3K Inhibitor BKM120, Carboplatin, and Pemetrexed Disodium in Treating Patients With Stage IV Non-Small Cell Recurrent Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer | Phase 1 | 2013-07-01 |
| Withdrawn | Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue i Adult Supratentorial Primitive Neuroectodermal Tumor (PNET), Ewing Sarcoma of Bone, Extraosseous Ewing Sarcoma | N/A | 2013-07-01 |
| Completed | Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Adenocarcinoma of the Prostate, Bone Metastases, Hormone-resistant Prostate Cancer | Phase 2 | 2013-06-07 |
| Completed | Quality of Life in Caregivers of Hospitalized Older Patients With Cancer Hematopoietic/Lymphoid Cancer, Unspecified Adult Solid Tumor, Protocol Specific | N/A | 2013-06-01 |
| Active Not Recruiting | Technology to Assess Vulnerable Older Adults With Cancer and Their Caregivers Cancer, Solid Tumor, Hematologic Malignancy | — | 2013-05-15 |
| Completed | Feasibility of Intraoperative Optical Imaging and Spectroscopy in Brain Tumors Brain Tumor | N/A | 2013-05-01 |
| Completed | Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung Cancer Stage I Colon Cancer, Stage I Rectal Cancer, Stage IA Non-small Cell Lung Cancer | N/A | 2013-01-01 |
| Withdrawn | Robotic-Assisted Surgery in Treating Patients With Spine Tumors Adult Spinal Cord Neoplasm, Spinal Bone Metastases, Spinal Cord Metastases | N/A | 2012-12-01 |
| Completed | Validation of an RLIP76 Assay in Humans Type 2 Diabetes | N/A | 2012-12-01 |
| Completed | Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Recurrent Adult Hodgkin Lymphoma | Phase 1 | 2012-11-09 |
| Completed | Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esop Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach | Phase 2 | 2012-11-01 |
| Completed | Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission | Phase 1 | 2012-10-29 |
| Terminated | Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic Acid Estrogen Receptor-positive Breast Cancer, Invasive Ductal Breast Carcinoma, Progesterone Receptor-positive Breast Cancer | N/A | 2012-09-14 |
| Withdrawn | Continuous Intraventricular Methotrexate in Treating Patients With Leptomeningeal Disease Leptomeningeal Metastases | N/A | 2012-09-01 |
| Completed | Robotic Assisted Laparoscopic Prostatectomy With or Without Pelvic Drain Placement in Reducing Adverse Events Perioperative/Postoperative Complications, Prostate Cancer | Phase 3 | 2012-08-24 |
| Terminated | Feasibility of a Supportive Education Program for Latina Breast Cancer Survivors Cancer Survivor, Stage I Breast Cancer, Stage II Breast Cancer | N/A | 2012-08-01 |
| Completed | Palliative Care Intervention in Patients With Solid Tumors Participating in Phase I Clinical Trials Unspecified Adult Solid Tumor, Protocol Specific | N/A | 2012-07-01 |
| Active Not Recruiting | Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer Locally Advanced Breast Carcinoma, Metastatic Breast Carcinoma, Recurrent Breast Carcinoma | Phase 2 | 2012-06-19 |
| Active Not Recruiting | Peer Navigator Education in Improving Survivorship Care in African American Breast Cancer Survivors Breast Cancer | N/A | 2012-06-01 |
| Withdrawn | Nursing Intervention in Supporting Family Caregivers of Patients Undergoing Stem Cell Transplant Anxiety Disorder, Depression, Fatigue | N/A | 2012-05-01 |
| Terminated | Minimally Invasive Surgery in Treating Patients With Spinal Tumors Adult Spinal Cord Neoplasm, Recurrent Adult Spinal Cord Neoplasm, Spinal Bone Metastases | N/A | 2012-05-01 |
| Active Not Recruiting | Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients Wit Inflammatory Breast Cancer, Stage IIA Breast Cancer, Stage IIIA Breast Cancer | Phase 2 | 2012-02-15 |
| Completed | Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach | Phase 1 / Phase 2 | 2012-02-01 |
| Withdrawn | Laparoscopic Surgery or Robotic-Assisted Laparoscopic Surgery in Treating Patients With Rectal Cancer That Can Recurrent Rectal Cancer, Stage I Rectal Cancer, Stage II Rectal Cancer | N/A | 2011-12-01 |
| Completed | Axitinib Before Surgery in Treating Patients With High-Risk Prostate Cancer Stage III Prostate Cancer, Stage IV Prostate Cancer | Phase 2 | 2011-10-28 |
| Completed | Fluorescence Imaging in Finding Tumors in Patients With Kidney Tumors Recurrent Renal Cell Cancer, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer | Phase 1 | 2011-10-20 |
| Completed | Brentuximab Vedotin Before Autologous Stem Cell Transplant in Treating Patients With Hodgkin Lymphoma Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma | Phase 2 | 2011-10-20 |
| Completed | Bortezomib and Rituximab in Treating Patients With Mantle Cell Lymphoma Who Have Previously Undergone Stem Cel Contiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Recurrent Mantle Cell Lymphoma | Phase 2 | 2011-10-03 |
| Completed | Spiritual Care in Improving Quality of Life of Patients, Caregivers, and Hospital Staff Malignant Neoplasm | N/A | 2011-10-01 |
| Completed | Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer Recurrent Colon Cancer, Recurrent Gastric Cancer, Recurrent Pancreatic Cancer | Phase 1 | 2011-10-01 |
| Active Not Recruiting | Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients Wit Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma | Phase 1 / Phase 2 | 2011-09-19 |
| Active Not Recruiting | The Hurria Older PatiEnts (HOPE) With Breast Cancer Study Breast Cancer | — | 2011-09-09 |
| Active Not Recruiting | Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Loca Breast Neoplasms, HER2/Neu Positive, Geriatric Health Services | Phase 2 | 2011-04-20 |
| Withdrawn | Fludeoxyglucose F 18 PET/CT Scans in Predicting Therapy Response in Patients With Stage IIIA Non-Small Cell Lu Stage IIIA Non-small Cell Lung Cancer | N/A | 2011-04-01 |
| Terminated | Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Lymphoepithelioma of the Nasopharynx, Recurrent Lymphoepithelioma of the Oropharynx | N/A | 2011-04-01 |
| Completed | Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer | Phase 1 | 2011-04-01 |
| Active Not Recruiting | Positron Emission Tomography in Women With Advanced HER2-Positive Breast Cancer Breast Cancer, Stage IV Breast Cancer | N/A | 2011-03-16 |
| Terminated | Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treati Liver Metastases, Recurrent Colon Cancer, Recurrent Rectal Cancer | Phase 2 | 2011-03-01 |
| Completed | Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Don Autologous Hematopoietic Stem Cell Transplant Recipient, Loss of Chromosome 17p, Plasma Cell Leukemia | Phase 1 | 2011-01-28 |
| Active Not Recruiting | Addressing Stigma in Screening and Diagnostic Delay for Cervical Cancer Cervical Cancer Screening | N/A | 2011-01-01 |
| Completed | Pazopanib Hydrochloride in Treating Patients With Stage IV Kidney Cancer Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer | Phase 2 | 2010-12-08 |
| Active Not Recruiting | Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia | — | 2010-12-01 |
| Completed | Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma | Phase 1 | 2010-12-01 |
| Completed | Pilot Study of Secondary Causes of Osteopenia/Osteoporosis in Adults With Breast and Prostate Cancer Breast Cancer, Prostate Cancer, Osteopenia | — | 2010-11-01 |
| Active Not Recruiting | Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer No Evidence of Disease, BRCA1 Syndrome, BRCA2 Syndrome | N/A | 2010-09-03 |
| Completed | A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Col Adult Anaplastic Astrocytoma, Recurrent Grade III Glioma, Recurrent Grade IV Glioma | Phase 1 | 2010-08-01 |
| Active Not Recruiting | Long Term Follow-Up in Patients With Stage 0-IIIC Breast Cancer Breast Cancer | — | 2010-07-06 |
| Terminated | Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload Iron Overload, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Phase 2 | 2010-07-01 |
| Completed | Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast Cancer Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer | Phase 1 | 2010-05-17 |
| Terminated | Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin L Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma | Phase 1 | 2010-05-01 |
| Completed | Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Meningioma | Phase 1 | 2010-05-01 |
| Completed | Plerixafor and Filgrastim Following Cyclophosphamide for Stem Cell Mobilization in Patients With Multiple Myel Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma | Phase 1 | 2010-04-01 |
| Terminated | Gene Transfer for HIV Using Autologous T Cells HIV-1 Infection | EARLY_Phase 1 | 2010-04-01 |
| Completed | Plasm Gastrin Concentrations in Response to Nexium Administration in Healthy Volunteers Healthy | Phase 1 | 2010-03-01 |
| Terminated | Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Rece Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer | N/A | 2010-01-01 |
| Completed | 5-Fluoro-2'-Deoxycytidine and Tetrahydrouridine in Treating Patients With Acute Myeloid Leukemia or Myelodyspl Adult Acute Myeloid Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes | Phase 1 | 2009-12-01 |
| Completed | Rescue Immunotolerance Study in Induction of Immune Tolerance (ITI)-Experienced Patients (RES.I.S.T. Experienc Severe Hemophilia A | N/A | 2009-11-03 |
| Withdrawn | Reduced-Intensity Preparative Regimen for Allogeneic Stem Cell Transplantation in Patients With Severe Aplasti Severe Aplastic Anemia | N/A | 2009-11-01 |
| Completed | MIRNA Profiling of Breast Cancer in Patients Undergoing Neoadjuvant or Adjuvant Treatment for Locally Advanced Breast Cancer | — | 2009-11-01 |
| Withdrawn | Study of First TIME Immunotolerance Induction in Severe Hemophilia A Patients With Inhibitor at High Risk of F Severe Hemophilia A | N/A | 2009-09-25 |
| Completed | Effects of Palliative Care on Quality of Life and Symptom Control in Patients With Stage I, Stage II, or Stage Lung Cancer | N/A | 2009-09-01 |
| Completed | Palliative Care Teaching Sessions for Family Caregivers of Patients With Non-Small Cell Lung Cancer Lung Cancer | N/A | 2009-09-01 |
| Active Not Recruiting | Comparing the Reliability of Expressed Prostatic Secretion (EPS) and Post Massage Urine (PMU) for the Predicti Conditions Influencing Health Status, Healthy, Prostate Cancer | N/A | 2009-07-14 |
| Completed | Assessment of Older Adults With Cancer: Feasibility of Computer Survey Methodology Assessment, Geriatric | — | 2009-07-01 |
| Completed | Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm | Phase 1 | 2009-07-01 |
| Completed | Detection of Human Beta Cell Death in Type 1 Diabetes Mellitus (T1DM) by Methylation Specific Polymerase Chain Type 1 Diabetes Mellitus | — | 2009-07-01 |
| Active Not Recruiting | Longitudinal Impact of Adjuvant Chemotherapy on Functional Status, Comorbidity and Quality of Life Breast Cancer | — | 2009-06-11 |
| Terminated | Axillary Lymph Node Preservation Surgery in Reducing Lymphedema in Patients With Breast Cancer Breast Cancer | Phase 1 / Phase 2 | 2009-06-01 |
| Completed | Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer Colorectal Cancer | Phase 1 | 2009-03-11 |
Showing the 500 most recent trials.